Dingkun Gui

2.1k total citations · 1 hit paper
55 papers, 1.7k citations indexed

About

Dingkun Gui is a scholar working on Nephrology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Dingkun Gui has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nephrology, 20 papers in Molecular Biology and 9 papers in Complementary and alternative medicine. Recurrent topics in Dingkun Gui's work include Chronic Kidney Disease and Diabetes (14 papers), Renal Diseases and Glomerulopathies (9 papers) and Traditional Chinese Medicine Analysis (8 papers). Dingkun Gui is often cited by papers focused on Chronic Kidney Disease and Diabetes (14 papers), Renal Diseases and Glomerulopathies (9 papers) and Traditional Chinese Medicine Analysis (8 papers). Dingkun Gui collaborates with scholars based in China, Macao and Italy. Dingkun Gui's co-authors include Niansong Wang, Yongping Guo, Jianhua Huang, Yifang Chen, Jianguo Chen, Wenzhen Xiao, Youhua Xu, Feng Wang, Ruonan Zhai and Jianguo Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Dingkun Gui

49 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway

2024 56 citations Yadi Liu, Ruixue Dong et al. Phytomedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dingkun Gui China	24	690	443	295	279	193	55	1.7k
Yonggui Wu China	31	1.1k 1.6×	657 1.5×	220 0.7×	245 0.9×	199 1.0×	101	2.4k
Lei Du China	28	761 1.1×	216 0.5×	139 0.5×	335 1.2×	259 1.3×	44	1.7k
Xi Dong China	26	791 1.1×	141 0.3×	167 0.6×	389 1.4×	116 0.6×	60	1.7k
Guixia Ding China	25	937 1.4×	633 1.4×	74 0.3×	178 0.6×	202 1.0×	68	2.0k
Xiangming Qi China	21	416 0.6×	313 0.7×	160 0.5×	127 0.5×	114 0.6×	50	1.1k
Hua Miao China	26	899 1.3×	407 0.9×	161 0.5×	191 0.7×	81 0.4×	54	1.8k
Yunman Wang China	20	421 0.6×	365 0.8×	114 0.4×	158 0.6×	72 0.4×	36	1.1k
Wenpeng Cui China	26	1.1k 1.5×	431 1.0×	59 0.2×	162 0.6×	219 1.1×	92	2.1k
Ke Fang China	22	603 0.9×	112 0.3×	102 0.3×	251 0.9×	260 1.3×	48	1.4k

Countries citing papers authored by Dingkun Gui

Since Specialization

Citations

This map shows the geographic impact of Dingkun Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingkun Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingkun Gui more than expected).

Fields of papers citing papers by Dingkun Gui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingkun Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingkun Gui. The network helps show where Dingkun Gui may publish in the future.

Co-authorship network of co-authors of Dingkun Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Dingkun Gui. A scholar is included among the top collaborators of Dingkun Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingkun Gui. Dingkun Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yadi, et al.. (2025). RNA Modification in Metabolism. MedComm. 6(3). e70135–e70135.

Cao, Ziyi, et al.. (2025). Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine. Frontiers in Endocrinology. 16. 1631312–1631312.

Yang, Liu, Michael S. Hu, Yilan Shen, et al.. (2025). Protective effects of Notoginsenoside R2 on reducing lipid accumulation and mitochondrial dysfunction in diabetic nephropathy through regulation of c-Src. Chinese Medicine. 20(1). 10–10. 1 indexed citations

Liu, Yadi, Ruixue Dong, Yiran Li, et al.. (2024). Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway. Phytomedicine. 126. 155437–155437. 56 indexed citations breakdown →

Dong, Ruixue, Xi Zhang, Yadi Liu, et al.. (2023). Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease. Phytomedicine. 112. 154700–154700. 59 indexed citations

Xu, Youhua, et al.. (2023). Combination of Astragalus membranaceus and Panax notoginseng as Main Components in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2023(1). 2945234–2945234. 4 indexed citations

Gui, Dingkun, et al.. (2023). Evaluation on the Efficacy and Safety of Panax Notoginseng Saponins in the Treatment of Stroke among Elderly People: A Systematic Review and Meta‐Analysis of 206 Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2023(1). 4312489–4312489. 2 indexed citations

Zhang, Wei, et al.. (2023). The Efficacy and Safety of Astragalus as an Adjuvant Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Integrative and Complementary Medicine. 30(1). 11–24. 2 indexed citations

Gui, Dingkun, et al.. (2022). Efficacy and Safety of Salvia miltiorrhiza for Treating Chronic Kidney Diseases: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–18. 7 indexed citations

10.

Zhao, Tingting, Junling Gu, Zhe Wang, et al.. (2022). Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axis. Chinese Medicine. 17(1). 22–22. 36 indexed citations

11.

Zhao, Tingting, et al.. (2022). Astragaloside IV Improves the Barrier Damage in Diabetic Glomerular Endothelial Cells Stimulated by High Glucose and High Insulin. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 5 indexed citations

12.

Wang, Zhe, Tingting Zhao, Ruixue Dong, et al.. (2021). Total flavonoids of Astragalus Ameliorated Bile Acid Metabolism Dysfunction in Diabetes Mellitus. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 15 indexed citations

13.

Wei, Gang, Honglin Sun, Kai Dong, et al.. (2021). The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metabolism. 33(10). 2021–2039.e8. 71 indexed citations

14.

Xie, Lixin, Rongwei Zhai, Tai C. Chen, et al.. (2020). Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Xue, Rui, Ruonan Zhai, Ling Xie, et al.. (2020). Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats through Modulating PTEN-PDK1-Akt-mTOR Pathway. Journal of Diabetes Research. 2020. 1–12. 16 indexed citations

16.

Su, Jun, et al.. (2020). Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury. Molecular Biology Reports. 47(10). 8023–8035. 20 indexed citations

17.

Zhai, Ruonan, Guihua Jian, Ling Xie, et al.. (2019). Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research. 2019. 1–14. 23 indexed citations

18.

Fan, Ying, Jing Zhang, Wenzhen Xiao, et al.. (2017). Rtn1a-Mediated Endoplasmic Reticulum Stress in Podocyte Injury and Diabetic Nephropathy. Scientific Reports. 7(1). 323–323. 46 indexed citations

19.

Peng, Ai, et al.. (2007). Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide. Journal of Ethnopharmacology. 116(3). 413–421. 24 indexed citations

20.

Nanni, G, et al.. (1984). [Home total parenteral nutrition].. PubMed. 39(5). 311–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact